admin

Given the sector’s intensity, the idea of buying anti-metaverse stocks seems completely ludicrous. You’ve undoubtedly heard of the metaverse—the phenomenon that represents the next evolution in internet connectivity. While technology experts have been raving about this development, Facebook offered the biggest catalyst, changing its corporate brand to Meta Platforms (NASDAQ:FB). To be completely fair, you
0 Comments
Black Diamond Therapeutics (NASDAQ:BDTX) and Cardiff Oncology (NASDAQ:CRDF) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, institutional ownership, profitability and risk. Valuation & Earnings This table compares Black Diamond Therapeutics and Cardiff Oncology’s revenue, earnings
0 Comments
Deciphera Pharmaceuticals (NASDAQ:DCPH) is a biotech company that develops drugs mainly for the treatment of cancer. Right now, DCPH stock shares are down nearly 85% year-to-date (YTD), at $7.70 as of the close of Nov. 29. Source: Iryna Imago / Shutterstock.com Of course, with Thanksgiving just over, it’s probably appropriate to note that I’m thankful for
0 Comments
In this article NCLH AAL BYND BNTX An American Airlines plane lands at Ronald Reagan Washington National Airport November 23, 2021 in Arlington, Virginia. Drew Angerer | Getty Images Check out the companies making headlines in midday trading Tuesday. American Airlines, Norwegian Cruise Line — Travel stocks retreated, as investors continued to weigh the risks
0 Comments
Tech stocks have come under pressure in recent days. Nonetheless, the Nasdaq 100 Technology Sector index has far outperformed the S&P 500 index, gaining more than 33% over the past year compared to 26% for the S&P 500 index. Wall Street enjoyed the explosive demand for enterprise software services, data center expansions, financial technology (fintech)
0 Comments
Jim Cramer on CNBC’s Halftime Report. Scott Mlyn | CNBC CNBC’s Jim Cramer said he doesn’t feel comfortable buying into Monday’s early stock market bounce, following Friday’s omicron-driven plunge, because the selling could resume in the event of future negative news about the highly mutated Covid variant. The Dow Jones Industrial Average — which had
0 Comments